Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Ray Therapeutics Lands $6M Seed Round

2022-01-04
SAN DIEGO, CA, Ray Therapeutics today announced the closing of a $6 million seed financing round, led by 4BIO Capital.
Ray Therapeutics, a biotech company developing optogenetic gene therapies for patients with blinding diseases, today announced the closing of a $6M seed financing round, led by 4BIO Capital.

Ray Therapeutics is developing novel optogenetics gene therapies for patients with blinding diseases. The company is developing its lead candidate Ray-001 in retinitis pigmentosa, a degenerative retinal disease with significant unmet medical need. The company's mission is to use optogenetics to restore vision, independent of genetic mutation for patients with inherited retinal diseases.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors